Gain insights to de-risk and accelerate your trials. Explore with us the value of integrating precision medicine into your clinical trials — from patient selection to operational efficiency.

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Molecular testing of colorectal cancers (CRCs) to improve patient care and outcomes of targeted and conventional therapies has been the center of many recent studies, including clinical trials.